chemotherapy-induced nausea and vomiting
Conditions
Interventions
Auricular point pressing group:The method of Control group and Auricular Pressing Beans
Auricular acupuncture group:The method of Control group and Auricular acupuncture
Control group:Routine nursing and intravenous drip of tropisetron hydrochloride injection
Sponsors
Affiliated Hospital of Nanjing University of Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Pathologically confirmed diagnosis of malignant tumor; 2. Aged 18-75 years old; 3. Receiving cisplatin chemotherapy; 4. KPS score = 60 points; 5. Expected survival = 6 months; 6. Identify their own disease and agree to participate in this study and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with concurrent chemoradiotherapy; 2. Patients with coagulation dysfunction or platelet abnormalities; 3. Patients with auricular skin ulceration or allergy to adhesive plaster; 4. Patients with nausea and vomiting caused by intestinal obstruction and other reasons; 5. Patients who are receiving other antiemetic drugs except this trial and cannot determine the efficacy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Abbreviated Nutritional Appetite Assessment Scale (SNAQ);Chinese MASCC Antiemetic Assessment Tool (MAT Scale); | — |
Secondary
| Measure | Time frame |
|---|---|
| Nausea and Vomiting Life Function Index (FLIE); | — |
Countries
China
Contacts
Public ContactYanyan He
Outcome results
None listed